Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood test can predict long-term risk of death in patients with shortness of breath

14.02.2006


Researchers from Massachusetts General Hospital (MGH) have shown that a blood test previously found useful for diagnosing heart failure and determining prognosis in several cardiovascular conditions can also predict the risk of death among patients coming to hospital emergency departments with shortness of breath. Their report in the Feb. 14 Archives of Internal Medicine describes how measuring levels of a protein called NT-proBNP was the most powerful predictor of whether patients would die within the year.


"We found that, regardless of whether the patient had been diagnosed with heart failure, elevated levels of this protein were strongly prognostic for death at one year and low levels identified those at the lowest risk," says James Januzzi Jr., MD, of the MGH Cardiology Division, the paper’s lead author. "Based on these results, we recommend that every patient coming to a hospital with shortness of breath be tested for NT-proBNP."

NT-proBNP is a natriuretic peptide, a protein produced when the cardiac muscle is under stress. In recent years these proteins have been investigated as assays for various forms of cardiovascular disease. In April 2005, members of the same MGH research team published the PRIDE study, which enrolled almost 600 patients who came to the MGH Emergency Department with shortness of breath. The PRIDE study showed that emergency department testing for NT-proBNP could help diagnose heart failure in those patients, providing a definitive diagnosis when the result was above specific levels and ruling it out when results were below an identified point.

The current study, designed to evaluate the long-term prognostic usefulness of the test, followed up on the patients in the PRIDE study. The research team contacted primary care physicians or cardiologists for each of the study participants, or reviewed hospital records, to determine their status a year after the original emergency visit. The results, which included data from all but four of the PRIDE study participants, showed that the NT-proBNP measurement made in the emergency department was a more accurate predictor of the risk of death during the following year than were other known measurements of cardiac risk.



"One of the more impressive findings in our study was the remarkably strong prognostic ability of NT-proBNP measurement in patients with shortness of breath from all causes," Januzzi added. "An elevated NT-proBNP was as strong a predictor of death in patients without heart failure as it was for those with it. And remarkably, among those found to have heart failure in the original visit, no patient with an NT-proBNP level below a certain point died during the study period.

"Elevations of NT-proBNP can be used not only to determine the diagnosis and the best hospital setting for treatment but also to estimate longer-term prognosis, allowing us to identify patients needing more intensive treatment and follow-up," he adds. "The next logical step is to evaluate treatment interventions for those with higher NT-proBNP levels to see if we can reduce their considerable risk for death." Januzzi is currently directing a randomized clinical trial of medical therapy guided by NT-proBNP measurement for patients with recent heart failure.

The study’s coauthors are Rahul Sakhuja, MD, MPP, Michelle O’Donoghue, MD, Aaron Baggish, MD, Saif Anwaruddin, MD, Claudia Chae, MD, MPH, Renee Cameron, Daniel Krauser, MD, Roderick Tung, MD, and Carlos Camargo Jr., MD, of MGH, and Donald Lloyd-Jones, MD, ScM, of the Feinberg School of Medicine at Northwestern University. The study was supported by a grant from Roche Diagnostics, which manufacturers the NT-proBNP assay studied but had no role in conducting the investigation or reporting the results.

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu/

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Antarctic landscape insights keep ice loss forecasts on the radar

20.11.2017 | Earth Sciences

Filling the gap: High-latitude volcanic eruptions also have global impact

20.11.2017 | Earth Sciences

Water world

20.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>